MII IG Kerndatensatz-Modul Onkologie
2027.0.0-ballot.1 - Germany

This page is part of the MII IG Kerndatensatz-Modul Onkologie (v2027.0.0-ballot.1: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions

: mii-exa-onko-tumorkonferenz-pure-molecular

Raw xml | Download


<CarePlan xmlns="http://hl7.org/fhir">
  <id value="mii-exa-onko-tumorkonferenz-pure-molecular"/>
  <meta>
    <profile
             value="https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/StructureDefinition/mii-pr-onko-tumorkonferenz|2027.0.0-ballot.1"/>
  </meta>
  <language value="de"/>
  <text>
    <status value="generated"/>
    <div xml:lang="de" lang="de"><hr/><p><b>German</b></p><hr/><p class="res-header-id"><b>Generated Narrative: CarePlan mii-exa-onko-tumorkonferenz-pure-molecular</b></p><a name="de-mii-exa-onko-tumorkonferenz-pure-molecular"> </a><a name="de-hcmii-exa-onko-tumorkonferenz-pure-molecular"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-mii-pr-onko-tumorkonferenz.html">MII PR Onkologie Tumorkonferenz</a> version: 2027.0.0-ballot.1</p></div><p><b>identifier</b>: Tumorkonferenz_Molecular_002</p><p><b>status</b>: Active</p><p><b>intent</b>: Plan</p><p><b>category</b>: <span title="Codes:{https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-therapieplanung-typ praeth}">Molekulares Tumorboard - Precision Medicine</span></p><p><b>subject</b>: <a href="Patient-mii-exa-onko-molecular-board-patient.html">Maria Müller  Female, DoB: 1968-07-22 ( https://www.medizininformatik-initiative.de/fhir/sid/patienten#MTB-2024-001)</a></p><p><b>created</b>: 2024-01-16</p><p><b>addresses</b>: <a href="Condition-primaertumor-example.html">Condition Bösartige Neubildung: Brustdrüse, nicht näher bezeichnet</a></p><blockquote><p><b>activity</b></p><p><b>progress</b>: </p><blockquote><div><p>HER2+ with T790M mutation and brain metastases - specific agent sequence based on resistance profile</p>
</div></blockquote><p><b>reference</b>: <a href="RequestGroup-mii-exa-onko-molecular-her2-alternatives.html">RequestGroup zielgerichtete Substanzen</a></p></blockquote><blockquote><p><b>activity</b></p><p><b>progress</b>: </p><blockquote><div><p>Neurosurgical consultation recommended for brain metastases management</p>
</div></blockquote><p><b>reference</b>: <a href="ServiceRequest-mii-exa-onko-molecular-surgery-request.html">ServiceRequest Consultation</a></p></blockquote></div>
  </text>
  <identifier>
    <value value="Tumorkonferenz_Molecular_002"/>
  </identifier>
  <status value="active"/>
  <intent value="plan"/>
  <category>
    <coding>
      <system
              value="https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-therapieplanung-typ"/>
      <code value="praeth"/>
    </coding>
    <text value="Molekulares Tumorboard - Precision Medicine"/>
  </category>
  <subject>🔗 
    <reference value="Patient/mii-exa-onko-molecular-board-patient"/>
  </subject>
  <created value="2024-01-16"/>
  <addresses>🔗 
    <reference value="Condition/primaertumor-example"/>
  </addresses>
  <activity>
    <progress>
      <text
            value="HER2+ with T790M mutation and brain metastases - specific agent sequence based on resistance profile"/>
    </progress>
    <reference>🔗 
      <reference
                 value="RequestGroup/mii-exa-onko-molecular-her2-alternatives"/>
    </reference>
  </activity>
  <activity>
    <progress>
      <text
            value="Neurosurgical consultation recommended for brain metastases management"/>
    </progress>
    <reference>🔗 
      <reference
                 value="ServiceRequest/mii-exa-onko-molecular-surgery-request"/>
    </reference>
  </activity>
</CarePlan>